How many doses of semaglutide (Wegovy) are in a Wegovy pen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Wegovy Pen Dosing

Each Wegovy pen contains a single dose of semaglutide—one pen delivers one injection.

Pen Configuration and Dosing

  • Wegovy is supplied as single-dose, pre-filled pens, with each pen containing one specific dose strength for subcutaneous injection once weekly 1, 2.

  • The medication follows a 16-week titration schedule with different pen strengths used at each phase: 0.25 mg weekly for weeks 1-4,0.5 mg weekly for weeks 5-8,1.0 mg weekly for weeks 9-12,1.7 mg weekly for weeks 13-16, and finally the maintenance dose of 2.4 mg weekly starting at week 17 1, 2.

  • Each pen is designed for single use only—after administering the dose, the pen should be discarded 2.

Practical Prescribing Considerations

  • Patients will need four pens per month once they reach the maintenance dose of 2.4 mg weekly (one pen per week) 1.

  • During the titration phase, prescriptions should specify the exact dose strength needed for that 4-week period, as each titration step requires pens of a different strength 1, 2.

  • The gradual dose escalation over 16 weeks is essential to minimize gastrointestinal adverse effects, which occur in 17-44% of patients but are typically mild-to-moderate and transient 1.

Common Pitfall to Avoid

  • Do not confuse Wegovy pens with multi-dose insulin pens—Wegovy pens are single-dose devices, whereas some insulin delivery systems contain multiple doses 3. Each Wegovy injection requires a new pen.

References

Guideline

Pharmacological Management of Obesity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ozempic Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Differences in the dose accuracy of insulin pens.

Journal of diabetes science and technology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.